The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.


Journal

Stem cells and development
ISSN: 1557-8534
Titre abrégé: Stem Cells Dev
Pays: United States
ID NLM: 101197107

Informations de publication

Date de publication:
15 09 2020
Historique:
pubmed: 30 7 2020
medline: 3 9 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

Pluripotent stem cells are promising candidates for cell-based regenerative therapies. To avoid rejection of transplanted cells, several approaches are being pursued to reduce immunogenicity of the cells or modulate the recipient's immune response. These include gene editing to reduce the antigenicity of cell products, immunosuppression of the host, or using major histocompatibility complex-matched cells from cell banks. In this context, we have investigated the antigenicity of H-Y antigens, a class of minor histocompatibility antigens encoded by the Y chromosome, to assess whether the gender of the donor affects the cell's antigenicity. In a murine transplant model, we show that the H-Y antigen in undifferentiated embryonic stem cells (ESCs), as well as ESC-derived endothelial cells, provokes T- and B cell responses in female recipients.

Identifiants

pubmed: 32723003
doi: 10.1089/scd.2019.0299
pmc: PMC7482111
doi:

Substances chimiques

H-Y Antigen 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1179-1189

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL140236
Pays : United States

Références

Cytometry A. 2017 Jan;91(1):85-95
pubmed: 27403624
N Engl J Med. 1998 Oct 22;339(17):1177-85
pubmed: 9780337
Blood. 2007 Dec 15;110(13):4576-83
pubmed: 17785583
Stem Cells Dev. 2015 Jan 1;24(1):1-10
pubmed: 25244598
Transplant Bull. 1955;2:148-9
pubmed: 12334405
Blood. 2008 May 1;111(9):4817-26
pubmed: 18299450
N Engl J Med. 1969 Apr 3;280(14):735-9
pubmed: 4886455
F1000Res. 2017 May 26;6:748
pubmed: 28663787
Blood. 2000 Feb 1;95(3):1100-5
pubmed: 10648428
Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17
pubmed: 20578106
Nature. 2011 May 13;474(7350):212-5
pubmed: 21572395
Immunol Res. 2014 May;58(2-3):249-58
pubmed: 24781195
Circ Res. 2019 Mar 15;124(6):843-845
pubmed: 30870126
J Clin Invest. 2015 Jul 1;125(7):2551-7
pubmed: 26132109
Lancet. 2003 Aug 23;362(9384):610-5
pubmed: 12944060
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Lancet. 1966 Sep 24;2(7465):662-5
pubmed: 4162350
Eur Heart J. 2015 Apr 1;36(13):806-16
pubmed: 25368203
Science. 1995 Sep 15;269(5230):1515-6
pubmed: 7667633
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Nat Biotechnol. 2006 Nov;24(11):1412-9
pubmed: 17086173
Blood. 2001 Oct 1;98(7):2043-51
pubmed: 11567988
Blood. 1998 Nov 15;92(10):3515-20
pubmed: 9808542
Cell. 2014 Oct 9;159(2):428-39
pubmed: 25303535
Blood. 2000 Nov 1;96(9):3126-32
pubmed: 11049993
Nat Commun. 2014 May 30;5:3903
pubmed: 24875164
J Heart Lung Transplant. 2012 May;31(5):459-66
pubmed: 22418079
Blood. 2005 Apr 1;105(7):2973-8
pubmed: 15613541
Biol Blood Marrow Transplant. 2016 May;22(5):850-61
pubmed: 26688192
J Immunol Methods. 2018 Feb;453:37-43
pubmed: 29174717
Cell Stem Cell. 2012 Aug 3;11(2):147-52
pubmed: 22862941
J Immunol Res. 2014;2014:518135
pubmed: 25126584
Stem Cells Transl Med. 2014 Oct;3(10):1116-24
pubmed: 25122690
Lancet. 1995 Oct 28;346(8983):1117-21
pubmed: 7475600
Nat Rev Drug Discov. 2017 Feb;16(2):115-130
pubmed: 27980341
Lancet. 2005 Dec 10;366(9502):2019-25
pubmed: 16338451
Lancet. 2008 Jul 5;372(9632):49-53
pubmed: 18603158
Methods Mol Biol. 2015;1343:81-95
pubmed: 26420710
Nat Biotechnol. 2011 Oct 02;29(10):886-91
pubmed: 21964415
Cell. 2015 Jul 2;162(1):184-97
pubmed: 26095251
J Vis Exp. 2012 Nov 02;(69):e4398
pubmed: 23149654
Nat Biotechnol. 2017 Jan;35(1):69-74
pubmed: 27941802
Nat Biotechnol. 2003 Oct;21(10):1200-7
pubmed: 14502203
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Bone Marrow Transplant. 1998 Oct;22(8):755-61
pubmed: 9827972
Stem Cells. 2013 Jun;31(6):1149-59
pubmed: 23495178
Cell Stem Cell. 2015 Jan 8;16(1):33-8
pubmed: 25465116
Front Immunol. 2014 Nov 06;5:529
pubmed: 25414699
J Immunol. 2000 Mar 1;164(5):2807-14
pubmed: 10679124
Bio Protoc. 2015;5(2):
pubmed: 27390767
J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93
pubmed: 17980256
Stem Cells Dev. 2008 Dec;17(6):1023-9
pubmed: 18491958
Blood. 2002 Apr 15;99(8):3027-32
pubmed: 11929796
Blood Adv. 2018 Oct 9;2(19):2419-2429
pubmed: 30262602

Auteurs

Xiaomeng Hu (X)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Simon T Kueppers (ST)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Nigel G Kooreman (NG)

Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA.
Department of Medicine, Stanford University, Stanford, California, USA.
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA.
Department of Vascular Surgery, Leiden University Medical Center, Leiden, the Netherlands.

Alessia Gravina (A)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.

Dong Wang (D)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Grigol Tediashvili (G)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Stephan Schlickeiser (S)

BIH-Center for Regenerative Therapies (BCRT), Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.
Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, BIH, Berlin, Germany.

Marco Frentsch (M)

BIH-Center for Regenerative Therapies (BCRT), Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.

Christos Nikolaou (C)

BIH-Center for Regenerative Therapies (BCRT), Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.

Andreas Thiel (A)

BIH-Center for Regenerative Therapies (BCRT), Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.

Sivan Marcus (S)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.

Sigrid Fuchs (S)

Institute of Human Genetics, University Medical Center Hamburg, Hamburg, Germany.

Joachim Velden (J)

Evotec AG, Histopathology and In Vivo Pharmacology, Hamburg, Germany.

Hermann Reichenspurner (H)

Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Hans-Dieter Volk (HD)

BIH-Center for Regenerative Therapies (BCRT), Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.
Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, BIH, Berlin, Germany.

Tobias Deuse (T)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.

Sonja Schrepfer (S)

Transplant and Stem Cell Immunobiology Lab, Department of Surgery, University of California, San Francisco, California, USA.
Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
University Heart & Vascular Center Hamburg, Hamburg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH